Bilateral atypical femoral fractures in a patient prescribed denosumab - A case report

Bone

Volumn 61, Issue , 2014, Pages 44-47

  Thompson, Robin N ^a   Armstrong, Ciara L ^a   Heyburn, Gary ^a  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

Atypical femoral fracture; Denosumab; Prophylactic nailing; Rheumatoid arthritis

Indexed keywords

ADALIMUMAB; ALENDRONIC ACID; DENOSUMAB; ETANERCEPT; INFLIXIMAB; LEFLUNOMIDE; METHYLPREDNISOLONE; TOCILIZUMAB;

ADULT; ARTICLE; BILATERAL ATYPICAL FEMORAL FRACTURE; BONE BIOPSY; BONE RADIOGRAPHY; BONE SCINTISCANNING; BONE TURNOVER; CASE REPORT; CEPHALOMEDULLARY NAILING; FEMALE; FEMUR FRACTURE; HISTOPATHOLOGY; HUMAN; INTRAMEDULLARY NAILING; LEG PAIN; MEDICAL RECORD REVIEW; OSTEOPOROSIS; RHEUMATOID ARTHRITIS;

ATYPICAL FEMORAL FRACTURE; DENOSUMAB; PROPHYLACTIC NAILING; RHEUMATOID ARTHRITIS;

ALENDRONATE; ANTIBODIES, MONOCLONAL, HUMANIZED; ARTHRITIS, RHEUMATOID; BONE DENSITY CONSERVATION AGENTS; FEMALE; FEMORAL FRACTURES; HUMANS; MIDDLE AGED; OSTEOPOROSIS;

EID: 84893409865     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2013.12.027     Document Type: Article

References (17)

1. Shane E., Burr D., et al. Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 2014, [Epub ahead of print 1/10/2013]. 10.1002/jbmr.1998.
2. Sutton E., Riche D.M. Denosumab, a RANK ligand inhibitor, for postmenopausal women with osteoporosis. Ann Pharmacother 2012, 46:1000-1009.
3. Watts B., Bilezikian J.P., et al. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis. Endocr Pract 2010, (Suppl. 3):1-37.
4. Burkiewicz J.S., Scarpace S.L., Bruce S.P. Denosumab in osteoporosis and oncology. Ann Pharmacother 2009, 43:1445-1455.
5. McClung M. Role of RANKL inhibition in osteoporosis. Arthritis Res Ther 2007, 9(Suppl. 1):S3.
6. Seraphim A., Al-Hadithy N., Mordecai S.C., Al-Nammari S. Do bisphosphonates cause femoral insufficiency fractures?. J Orthop Traumatol 2012, 13:171-177.
7. Compston J. Pathophysiology of atypical femoral fractures and osteonecrosis of the jaw. Osteoporos Int 2011, 22:2951-2961.
8. Ettinger B., Burr D.B., Ritchie R.O. Proposed pathogenesis for atypical femoral fractures: lessons from materials research. Bone 2013, 55:495-500.
9. Dell R.M., Adams A.L., et al. Incidence of atypical nontraumatic diaphyseal fractures of the femur. J Bone Miner Res 2012, 27:2544-2550.
10. Tamminen I.S., Yli-Kyyny T., et al. Incidence and bone biopsy findings of atypical femoral fractures. J Bone Miner Metab 2013, 31:585-594.
11. Thompson R.N., Phillips J.R., McCauley S.H., Elliott J.R., Moran C.G. Atypical femoral fractures and bisphosphonate treatment: experience in two large United Kingdom teaching hospitals. J Bone Joint Surg (Br) 2012, 94:385-390.
12. Cummings S.R., San Martin J., et al. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 2009, 361:756-765.
13. MHRA Drug Safety Update 2013 Volume 6, Issue 7. Denosumab 60mg: rare cases of atypical femoral fracture with long-term use [accessed 28/8/2013]. http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON239411.
14. MHRA drug analysis print [accessed 28/8/2013]. http://www.mhra.gov.uk/home/groups/public/documents/sentineldocuments/dap_1374834463819.pdf.
15. FDA Adverse Event Reporting System (FAERS): latest quarterly data files [accessed 1/11/2013]. http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/ucm082193.htm.
16. MHRA Drug Safety Update 2012 Volume 6, Issue 3. Denosumab: fatal cases of severe symptomatic hypocalcaemia, and risk of hypocalcaemia at any time during treatment - monitoring recommended [accessed 28/8/2013]. http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON199560.
17. Khan S.A., Kanis J.A., et al. Elimination and biochemical responses to intravenous alendronate in postmenopausal osteoporosis. J Bone Miner Res 1997, 12:1700-1707.